Bring more than the latest total cholesterol
A lipid panel reports several measures, including LDL, HDL, triglycerides, and total cholesterol. The values help inform risk, but the conversation should also include medical history and other factors. Ask which result is driving concern and why.
Bring previous reports when available so the clinician can see the pattern over time. Explain whether you were taking treatment when each test was done and mention any side effects or changes. You do not need to interpret the numbers before the visit. The aim is to give the clinician enough context to explain what matters for your next decision.
Sources: American Heart Association: How to Get Your Cholesterol Tested
Make family history specific and useful
Write down which relatives had heart attacks, strokes, very high cholesterol, or another known cardiovascular condition and their approximate age when it occurred. If the exact diagnosis is uncertain, say so rather than filling in the gap with a guess.
Some lipid conditions, including familial hypercholesterolemia and elevated lipoprotein(a), can run in families. Ask whether your history suggests an inherited factor and whether other relatives should discuss screening with their clinicians. Family history can change a prevention conversation, but it does not tell the whole story or mean that a cardiovascular event is inevitable.
Sources: American Heart Association: Genetic Cholesterol Conditions
Understand why an additional blood test is proposed
Lp(a) and apolipoprotein B, or ApoB, provide information beyond a standard lipid panel in particular contexts. The 2026 AHA/ACC dyslipidemia guideline recommends measuring Lp(a) at least once in a lifetime and selective use of ApoB to refine risk assessment.
Ask what a result would change in your plan, whether it needs repeating, and how it relates to the measurements you already have. Avoid treating any single marker as a verdict. The useful question is how all the information affects the choice of prevention strategy, goals, and follow-up for you.
Sources: American Heart Association: 2026 Guideline on the Management of Dyslipidemia
Ask how risk becomes a recommendation
Have the clinician explain how age, blood pressure, diabetes, smoking, kidney health, prior disease, and family history affect the discussion where relevant. Ask whether a short-term risk estimate applies to you and whether lifetime exposure changes the interpretation.
If a scan or another test is proposed, ask what uncertainty it could resolve and how different results would change care. If medicine is recommended, discuss the expected benefit, side effects, alternatives, and what happens if you do not tolerate it. The explanation should connect the recommendation to your situation rather than simply comparing a result with a laboratory reference range.
Build follow-up around a realistic plan
Ask which changes to prioritize and what support would make them achievable. A nutrition or activity plan should take account of your routines, preferences, mobility, time, and access. Tell the clinician about barriers without waiting for a follow-up that shows the plan was difficult to sustain.
If you start or adjust a treatment, clarify when to repeat testing and whom to contact about unwanted effects. Ask which measure the team will use to assess response. Keep the plan connected with primary care and any other specialists so prescriptions and follow-up have a clear owner.
Explore lipid and prevention care at Commons Clinic
Dr. Jenica Ortega includes lipidology, preventive cardiology, hypertension management, and women's cardiovascular health in her work at Commons Clinic. Her profile can help you prepare a focused consultation about your results and family history.
Bring the lab reports, a current medicine list, and the question that matters most to you. You might want to understand an inherited risk, decide about treatment, or reassess a plan that has been hard to follow. Ask the team to summarize which factors drive the recommendation, what you can change now, and when the results and next steps will be reviewed.
Connect a treatment target with your overall risk
The ACC’s 2026 guideline announcement emphasizes earlier attention to long-term exposure to harmful lipids and more personalized assessment. Ask why a particular goal fits your risk, how family history changes the discussion, and whether additional markers would resolve uncertainty. If a medicine is recommended, discuss how its benefit and possible unwanted effects will be assessed. Bring your past treatment experience, including the dose and symptoms when a medicine was difficult to tolerate. That creates a more useful conversation than treating one laboratory result as a complete decision.
Sources: ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol
Ask whether genetic information would change family care
Mayo Clinic explains that familial hypercholesterolemia can be diagnosed using clinical information and that genetic testing is helpful in some situations but is not always necessary. Ask what a genetic result would clarify for you and for first-degree relatives. If family details are incomplete, tell the clinician what you know and where the uncertainty lies. Discuss who should coordinate relatives’ assessment, how results will be explained, and whether genetic counseling would help. The goal is an actionable family plan, without asking you to interpret a genetic report on your own.
Sources: Familial hypercholesterolemia: Diagnosis and treatment
Make the most of your visit
Questions to bring to your consultation
Choose the questions that matter most to you. Bring them along, and ask us to explain anything that is unclear.
- Which lipid result matters most in my situation, and why?
- Does my family history suggest an inherited lipid condition?
- Should relatives discuss screening with their clinicians?
- Have I had Lp(a) measured, and would ApoB add useful information?
- What would an additional test change about my care?
- How are short-term risk and long-term exposure being considered?
- What benefit, side effects, and alternatives should I understand before treatment?
- Which goals and repeat tests will we use to assess the plan?
- Why does this treatment goal fit my overall risk and family history?
- Would a genetic test change my management or how relatives should be evaluated?
- Who will explain a genetic result and coordinate any recommended family assessment?
Sources & further reading
- American Heart Association: How to Get Your Cholesterol Tested
- American Heart Association: Genetic Cholesterol Conditions
- American Heart Association: 2026 Guideline on the Management of Dyslipidemia
- ACC/AHA Issue Updated Guideline for Managing Lipids, CholesterolAmerican College of Cardiology · Published March 13, 2026
- Familial hypercholesterolemia: Diagnosis and treatmentMayo Clinic · Published June 12, 2026
We use these medical sources to help explain your options and prepare you for a conversation with our team. Our guides feature our own clinicians; patient reviews describe individual experiences.
